Body dysmorphic disorder red flags belong on the same screening list as active infection and anaphylaxis, and Dr. Jennifer Thomas-Goering puts them there. Her red-flag list for an aesthetic consultation runs: active infection or inflammation, serious allergy or anaphylaxis, patients who may come in with body dysmorphia, and the patient who is pressuring you.
The first two are uncontroversial and every injector screens for them. The second two are judgment calls, they are the ones new injectors consistently talk themselves out of, and they are the two that most reliably produce the outcome nobody wants — a technically correct treatment and an inconsolable patient.
What she actually says
On body dysmorphia, her reasoning is about goal mismatch rather than diagnosis: "I don't find that I can be a good provider for them, because we have different goals. And so it's okay sometimes to say no."
On the pressuring patient, she is blunter: "Occasionally you'll have patients that will come in and they will demand things, and they will tell you what to do. You're the practitioner. You're the clinician. You're the one who is creating the plan. Of course it's collaborative, but they shouldn't be directing how you treat them."
Two red flags, one underlying principle: the consultation has failed to produce a shared plan, and injecting anyway does not fix that.
Red flag one: body dysmorphic disorder
The prevalence is not what most injectors assume
Body dysmorphic disorder has an estimated point prevalence of 2.4% in the US adult population (Koran LM, et al. CNS Spectr. 2008;13(4):316–322). In aesthetic practice it is substantially concentrated. A systematic review and meta-analysis of 33 publications found BDD in 15.04% of plastic surgery patients and 12.65% of dermatology patients (Ribeiro RVE. Aesthetic Plast Surg. 2017;41(4):964–970).
Set that against what practitioners believe. In a survey of American Society for Aesthetic Plastic Surgery members, respondents estimated that 2% of patients presenting for an initial cosmetic consultation had BDD — roughly the general-population rate, and roughly a seventh of what the pooled clinical data show (Sarwer DB. Aesthet Surg J. 2002;22(6):531–535).
If you inject full days, you are seeing this population regularly. The question is not whether it walks into your clinic. It is whether you recognise it.
Treating it does not treat it
The same survey found that 84% of responding surgeons had operated on a patient they believed was appropriate, only to realise afterwards that the patient had BDD, and 82% of those surgeons believed the outcome was poor.
The outcome data are more specific than that impression. In a study of 200 people with BDD, surgical and minimally invasive cosmetic treatments were more likely than other cosmetic procedures to reduce preoccupation with the specific treated body part — but overall BDD severity improved with only 2.3% of treatments (Crerand CE, Menard W, Phillips KA. Ann Plast Surg. 2010;65(1):11–16).
That number is the clinical argument, and it is worth stating to yourself in the room: the treatment this patient is asking for has, in the best available data, about a one-in-forty chance of making the underlying condition better. Nothing about your technique changes that denominator.
What it looks like at a consultation
You are not diagnosing. You are noticing a pattern that should slow you down:
- A preoccupation with a feature that you, examining carefully, either cannot perceive or would describe as slight.
- Disproportion between the described distress and the observable finding — distress that is interfering with work, relationships or leaving the house.
- Repetitive appearance-related behaviour surfacing in the history: mirror checking, camouflaging, comparing, photographing, repeatedly seeking reassurance.
- A history of multiple prior procedures, each of which "didn't work," across multiple providers.
- A patient who cannot articulate what result would satisfy them, or who moves the target when you propose something specific.
- Requests framed in terms of what the change will cause — a relationship, a job, an end to being looked at — rather than in terms of appearance.
Thomas-Goering's two consult questions do a great deal of the work here without anyone having to raise a diagnosis. What are you hoping will look different? and what result would disappoint you, even if the technique is technically correct? A patient whose answers are observable and bounded is a patient you can treat. A patient whose answers are unbounded, or who cannot produce one at all, is telling you the goal is not the one you can operate on.
Validated screening instruments exist — from the literature, not from this faculty
A note on attribution: Dr. Thomas-Goering flags body dysmorphia as a red flag but does not teach or endorse any particular screening instrument, and none of the tools below is attributed to her. They are cited here from the published literature so that clinicians who want a structured screen can find one.
Two are validated for cosmetic settings:
- The BDDQ (Body Dysmorphic Disorder Questionnaire), dermatology version. A brief self-report screen developed and validated in a cosmetic dermatologic surgery practice, reported with 100% sensitivity and 93% specificity against a clinician-administered diagnostic interview in the validation sample of 46 subjects (Dufresne RG, Phillips KA, Vittorio CC, Wilkel CS. Dermatol Surg. 2001;27(5):457–462).
- The COPS (Cosmetic Procedure Screening Questionnaire), developed specifically for cosmetic procedure settings (Veale D, Ellison N, Werner TG, Dodhia R, Serfaty MA, Clarke A. J Plast Reconstr Aesthet Surg. 2012;65(4):530–532).
Two caveats matter. These are screens, not diagnoses — a positive result means a conversation and, where appropriate, a referral to a mental health professional, never a label applied in your chart. And the validation samples are small; the 100% sensitivity figure comes from 46 subjects and should be read as promising rather than definitive.
What to do with a positive screen
Not a confrontation. A patient told they have a psychiatric condition by an injector they met twenty minutes ago will hear rejection, not care.
What works better is declining on the ground Thomas-Goering actually uses — goal mismatch — and offering the referral as an addition rather than a substitute:
"I've listened carefully, and I don't think I can give you what you're describing. What's bothering you is not something I can see in a way that a treatment would change, and if I injected you today I think you would be disappointed, and I don't want to do that to you. What I would like to do is put you in touch with someone who works with exactly this. It isn't instead of aesthetic treatment — it's so that if you do have treatment, it's the right one and it works for you."
Document the request, your examination, your reasoning, what you offered, and what the patient decided.
Red flag two: the patient who is pressuring you
Pressure is a safety problem, not an ego problem
It is easy to read "they shouldn't be directing how you treat them" as a statement about professional standing. It is not. Pressure is a red flag because of what it does to your decision-making in the next fifteen minutes.
A pressured injector places more product than they intended. Treats an area they were not confident about. Skips the part of the consultation that would have surfaced the problem. Agrees to a technique they do not normally use because the patient "had it done that way before." Every one of those is a technical risk that was created socially, and complications arising from them look, afterwards, exactly like ordinary complications.
It is also a predictor. A patient who will not accept your judgment before treatment will not accept it after treatment. The person telling you which product to use today is the person who will tell you the result is wrong at two weeks, and who will not accept your assessment of it. Dissatisfaction that begins before the needle rarely resolves after it.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Aesthetic & Injectable Training courses — live patients, expert faculty, and ongoing mentorship.
What pressure actually looks like
Distinguish it from enthusiasm and from being well-informed. A patient who arrives having researched the products is an asset. The red flag is a different pattern:
- Specifying product, volume or units and treating your clinical assessment as an obstacle.
- Rejecting the plan you propose without engaging with the reason for it.
- Escalating: naming another clinic that would do it, invoking cost, invoking the time they have taken off work.
- Requesting an amount or a placement you have already declined, later in the same visit.
- Pressure applied to your staff rather than to you — front desk, nurse, assistant. Ask your team. They see this before you do.
- Any request that you deviate from your own documented protocol "just this once."
The response
Reassert the structure calmly, and make the collaboration explicit rather than defensive:
"I want to be clear about how this works, because I think it'll help. You tell me what's bothering you and what you want to change — that part is yours and I need it. What product, how much and where is mine; that's the part I'm responsible for, and it's the part I can't hand over. What you're asking for isn't something I'm willing to do, and me doing something I don't think is right is not a good outcome for you either. Here's what I can offer instead."
Then hold it. If the pressure continues after a clear, respectful boundary, the visit is over — and the fact that they kept pushing after you explained your reasoning is itself the clinical finding.
Two supporting measures make this easier to sustain. First, a practice policy that no patient is treated at the consultation visit for first-time treatment plans removes the time pressure from the room entirely. Second, a consent process that is genuinely a conversation rather than a signature creates a natural, non-confrontational point at which a plan that both parties cannot agree on simply does not proceed.
Why saying no protects the practice
The commercial objection to both red flags is that declining costs you the case. It does, and the arithmetic still favours declining.
A dissatisfied patient in either category does not produce one lost appointment. They produce repeat visits you are not paid for, dissolving or reversal procedures you did not plan, staff time, a public review, and in the worst case a complaint to your board. Against that, the revenue from one treatment is not a close call.
Thomas-Goering names the pull honestly — "that's one of the hardest things for us to do, because we want to grow our practice, because we want to take care of the patients. But sometimes we just have to say no" — and the survey data suggest the profession as a whole finds it hard: only 30% of responding aesthetic surgeons considered BDD always a contraindication to cosmetic surgery.
What changes on Monday morning
Ask the disappointment question on every new patient. "What result would disappoint you, even if the technique was technically correct?" It is the single highest-yield question in this entire screen and it takes ten seconds.
Decide your position on a structured BDD screen before you need it, rather than improvising in the room. Whether or not you adopt the BDDQ or COPS, knowing they exist and having a referral pathway ready is what makes a positive finding actionable instead of paralysing.
Debrief your front desk. Pressure is usually applied to staff first. A team that knows to tell you is an early warning system you already employ.
Separate the consult from the treatment for first-time plans. Almost every bad decision in this article is a decision made under time pressure that would not have been made a week later.
Patient selection, consultation structure and the judgment behind declining a case are taught alongside injection technique in Empire Medical Training's Complete Botox Training and Complete Facial Aesthetic Training.
The red flags and clinical positions described here reflect Dr. Jennifer Thomas-Goering's clinical practice as taught in Empire Medical Training's hands-on curriculum. The prevalence data, outcome data and screening instruments are cited from the published literature and are not attributed to her. This article is educational, does not constitute mental health guidance, and is not a substitute for training.
About the author. Dr. Jennifer Thomas-Goering, DO, MBA, is a board-certified anesthesiologist, a clinical lead instructor and executive committee member at Empire Medical Training, and the founder of an aesthetics practice in Ann Arbor, Michigan.
Frequently Asked Questions
How common is body dysmorphic disorder in aesthetic patients?
Estimated point prevalence in the US adult population is 2.4%. A meta-analysis of 33 studies found it in 15.04% of plastic surgery patients and 12.65% of dermatology patients. Surveyed aesthetic surgeons estimated only 2% among their own consultations, which suggests the condition is substantially under-recognised in practice rather than rare in it.
Does cosmetic treatment help patients with body dysmorphic disorder?
Rarely. In a study of 200 people with BDD, surgical and minimally invasive treatments were more likely than other cosmetic procedures to reduce preoccupation with the specific treated area, but overall BDD severity improved with only 2.3% of treatments. Technique does not change that; the condition is not an appearance problem.
Is there a validated BDD screening tool for aesthetic practice?
Yes — the dermatology version of the Body Dysmorphic Disorder Questionnaire, validated in a cosmetic dermatologic surgery setting, and the Cosmetic Procedure Screening Questionnaire developed for cosmetic procedure settings. Both are screens rather than diagnoses; a positive result should prompt a conversation and a referral to a mental health professional.
How should an injector decline a patient with suspected body dysmorphia?
Not by naming a diagnosis. Decline on goal mismatch — that what is bothering them is not something a treatment can change, and that you believe they would be disappointed — then offer a referral as an addition rather than a substitute for care. Document the request, your examination, your reasoning and what was offered.
Why is a pressuring patient a clinical red flag?
Because pressure changes technical decisions. A pressured injector places more product, treats areas they were unsure about, skips screening steps and uses techniques they do not normally use. It is also predictive: a patient who will not accept your judgment before treatment will not accept your assessment of the result afterwards.
Disclaimer
This article reflects the clinical opinions and experience of Dr. Jennifer Thomas-Goering, DO, MBA, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.
